Cargando…

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

The upfront treatment of very elderly and frail patients with diffuse large B-cell lymphoma (DLBCL) is still a matter of debate. Herein, we report results of the metronomic all-oral DEVEC [prednisolone/deltacortene(®), vinorelbine (VNR), etoposide (ETO), cyclophosphamide] combined with i.v. rituxima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bocci, Guido, Pelliccia, Sabrina, Orlandi, Paola, Caridi, Matteo, Banchi, Marta, Musuraca, Gerardo, Di Napoli, Arianna, Bianchi, Maria Paola, Patti, Caterina, Anticoli-Borza, Paola, Battistini, Roberta, Casaroli, Ivana, Lanzolla, Tiziana, Tafuri, Agostino, Cox, Maria Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739472/ https://www.ncbi.nlm.nih.gov/pubmed/36498736 http://dx.doi.org/10.3390/jcm11237162

Ejemplares similares

Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162
por: Bocci, Guido, et al.
Publicado: (2023)

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
por: Cox, Maria Christina, et al.
Publicado: (2020)

Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
por: Banchi, Marta, et al.
Publicado: (2022)

Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study
por: Facondo, Giuseppe, et al.
Publicado: (2023)

Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach
por: Orlandi, Paola, et al.
Publicado: (2021)

Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy
por: Sales, María E., et al.
Publicado: (2019)

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
por: Allegrini, Giacomo, et al.
Publicado: (2012)

Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021)

Metronomic chemotherapy for triple negative breast cancer?
por: Di Desidero, Teresa, et al.
Publicado: (2016)

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
por: Bocci, G, et al.
Publicado: (2008)

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
por: Allegrini, G, et al.
Publicado: (2008)

Metronomic chemotherapy
por: Maiti, Rituparna
Publicado: (2014)

Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin’s disease
por: Ciccarone, Mariavita, et al.
Publicado: (2023)

Metronomic Chemotherapy with Vinorelbine Produces Clinical Benefit and Low Toxicity in Frail Elderly Patients Affected by Advanced Non-Small Cell Lung Cancer
por: D'Ascanio, Michela, et al.
Publicado: (2018)

Metronomics for thymic carcinoma
por: del Toro, Jacobo Muñoz, et al.
Publicado: (2014)

Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome
por: Gavriatopoulou, Maria, et al.
Publicado: (2020)

Metronomics: Intrinsic Anakoinosis Modulator?
por: Nicolas, André, et al.
Publicado: (2018)

Metronomic Chemotherapy in Prostate Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2022)

Systemic Lupus Erythematosus Presenting as Hematoma of the Hand Due to Acquired Inhibitors to Factor VIII: Early and Prolonged Remission Achieved with Upfront Rituximab
por: Zaidi, Abdul Rehman Z, et al.
Publicado: (2019)

Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma
por: Rogges, Evelina, et al.
Publicado: (2022)

VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide
por: Orlandi, P, et al.
Publicado: (2013)

DEBATE UPFRONT vs DELAYED TRANSPLANT
por: Gay, F.
Publicado: (2023)

Predictors of Emergency Room Access and Not Urgent Emergency Room Access by the Frail Older Adults
por: Gentili, Susanna, et al.
Publicado: (2021)

Head and neck cancer: metronomic chemotherapy
por: De Felice, Francesca, et al.
Publicado: (2015)

Metronomic Treatment with Low-Dose Trofosfamide Leads to a Long-Term Remission in a Patient with Docetaxel-Refractory Advanced Metastatic Prostate Cancer
por: Greiner, Jochen, et al.
Publicado: (2010)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
por: Di Desidero, Teresa, et al.
Publicado: (2019)

Balance and Gait of Frail, Pre-Frail, and Robust Older Hispanics
por: Vieira, Edgar R., et al.
Publicado: (2018)

Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets
por: Fecchi, Katia, et al.
Publicado: (2020)

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017)

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
por: Pusceddu, Sara, et al.
Publicado: (2022)

In Vivo Evaluation of TNF-Alpha in the Lungs of Patients Affected by Sarcoidosis
por: Galli, Filippo, et al.
Publicado: (2015)

Immunotherapy Combined with Metronomic Dosing: An Effective Approach for the Treatment of NSCLC
por: Skavatsou, Eleni, et al.
Publicado: (2021)

Surgery for Crohn’s disease: upfront or last resort?
por: Ahmed Ali, U, et al.
Publicado: (2022)

Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
por: Ferrandina, Gabriella, et al.
Publicado: (2014)

Risk and Protective Factors for Frailty in Pre-Frail and Frail Older Adults
por: Corral-Pérez, Juan, et al.
Publicado: (2023)

Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor
por: Conigliaro, Paola, et al.
Publicado: (2016)

[(18)F]FDG PET/CT in Patients Affected by SARS-CoV-2 and Lymphoproliferative Disorders and Treated with Tocilizumab
por: Signore, Alberto, et al.
Publicado: (2022)

Metronomic chemotherapy: changing the paradigm that more is better
por: Scharovsky, O.G., et al.
Publicado: (2009)

Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014)

Metronomic palliative chemotherapy in maxillary sinus tumor
por: Patil, Vijay M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4tg5bkjv6am9vcbt00bvnestc0